Good News Inspiration Inspiration JLS Foundation Living Life as a Contribution

Seattle Children’s Set to Launch First U.S. CAR T-Cell Clinical Trial for Children with Lupus

The John L. Scott Foundation helps support Seattle Children’s

Seattle Children’s | Casey Egan

Seattle Children’s has received FDA authorization to launch the first chimeric antigen receptor (CAR) T-cell clinical trial in the U.S. for children under 18 with the most common form of lupus.

Systemic lupus erythematosus is a chronic autoimmune disorder that affects multiple organ systems, resulting in significant morbidity and mortality. Approximately 20% of lupus patients have disease onset during childhood, and children with lupus are at particular risk for severe disease and worse long-term outcomes.

Read the full article: Seattle Children’s Set to Launch First U.S. CAR T-Cell Clinical Trial for Children with Lupus

Related posts

Seattle Children’s trading card project funded by John L. Scott Foundation

jlspr

John L. Scott Lake Tapps broker Lauri McLeod wins Rotarian of the Year Award

jlspr

Blood drive among John L. Scott Vancouver’s philanthropic efforts

jlspr